333 related articles for article (PubMed ID: 27484949)
1. microRNA-132/212 deficiency enhances Aβ production and senile plaque deposition in Alzheimer's disease triple transgenic mice.
Hernandez-Rapp J; Rainone S; Goupil C; Dorval V; Smith PY; Saint-Pierre M; Vallée M; Planel E; Droit A; Calon F; Cicchetti F; Hébert SS
Sci Rep; 2016 Aug; 6():30953. PubMed ID: 27484949
[TBL] [Abstract][Full Text] [Related]
2. Circular HDAC9/microRNA-138/Sirtuin-1 Pathway Mediates Synaptic and Amyloid Precursor Protein Processing Deficits in Alzheimer's Disease.
Lu Y; Tan L; Wang X
Neurosci Bull; 2019 Oct; 35(5):877-888. PubMed ID: 30887246
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models.
Liu Y; Zhang Y; Liu P; Bai H; Li X; Xiao J; Yuan Q; Geng S; Yin H; Zhang H; Wang Z; Li J; Wang S; Wang Y
Eur J Pharmacol; 2019 Jan; 843():134-144. PubMed ID: 30412727
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-128 suppresses tau phosphorylation and reduces amyloid-beta accumulation by inhibiting the expression of GSK3β, APPBP2, and mTOR in Alzheimer's disease.
Li S; Poon CH; Zhang Z; Yue M; Chen R; Zhang Y; Hossain MF; Pan Y; Zhao J; Rong L; Chu LW; Shea YF; Rogaeva E; Tu J; St George-Hyslop P; Lim LW; Song YQ
CNS Neurosci Ther; 2023 Jul; 29(7):1848-1864. PubMed ID: 36880288
[TBL] [Abstract][Full Text] [Related]
5. miR-200a-3p promotes b-Amyloid-induced neuronal apoptosis through down-regulation of SIRT1 in Alzheimer's disease.
Zhang QS; Liu W; Lu GX
J Biosci; 2017 Sep; 42(3):397-404. PubMed ID: 29358553
[TBL] [Abstract][Full Text] [Related]
6. Cerebrovascular microRNA Expression Profile During Early Development of Alzheimer's Disease in a Mouse Model.
Chum PP; Hakim MA; Behringer EJ
J Alzheimers Dis; 2022; 85(1):91-113. PubMed ID: 34776451
[TBL] [Abstract][Full Text] [Related]
7. Over-expression of miR-34a induces rapid cognitive impairment and Alzheimer's disease-like pathology.
Sarkar S; Engler-Chiurazzi EB; Cavendish JZ; Povroznik JM; Russell AE; Quintana DD; Mathers PH; Simpkins JW
Brain Res; 2019 Oct; 1721():146327. PubMed ID: 31295467
[TBL] [Abstract][Full Text] [Related]
8. miR-30a-5p induces Aβ production via inhibiting the nonamyloidogenic pathway in Alzheimer's disease.
Sun T; Zhao K; Liu M; Cai Z; Zeng L; Zhang J; Li Z; Liu R
Pharmacol Res; 2022 Apr; 178():106153. PubMed ID: 35257899
[TBL] [Abstract][Full Text] [Related]
9. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model.
Guedes JR; Custódia CM; Silva RJ; de Almeida LP; Pedroso de Lima MC; Cardoso AL
Hum Mol Genet; 2014 Dec; 23(23):6286-301. PubMed ID: 24990149
[TBL] [Abstract][Full Text] [Related]
10. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model.
Hirata-Fukae C; Li HF; Hoe HS; Gray AJ; Minami SS; Hamada K; Niikura T; Hua F; Tsukagoshi-Nagai H; Horikoshi-Sakuraba Y; Mughal M; Rebeck GW; LaFerla FM; Mattson MP; Iwata N; Saido TC; Klein WL; Duff KE; Aisen PS; Matsuoka Y
Brain Res; 2008 Jun; 1216():92-103. PubMed ID: 18486110
[TBL] [Abstract][Full Text] [Related]
11. Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer's disease.
Burgaletto C; Platania CBM; Di Benedetto G; Munafò A; Giurdanella G; Federico C; Caltabiano R; Saccone S; Conti F; Bernardini R; Bucolo C; Cantarella G
Cell Death Dis; 2021 Oct; 12(10):905. PubMed ID: 34611142
[TBL] [Abstract][Full Text] [Related]
12. Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice.
Oddo S; Caccamo A; Cheng D; Jouleh B; Torp R; LaFerla FM
J Neurochem; 2007 Aug; 102(4):1053-63. PubMed ID: 17472708
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-384 regulates both amyloid precursor protein and β-secretase expression and is a potential biomarker for Alzheimer's disease.
Liu CG; Wang JL; Li L; Wang PC
Int J Mol Med; 2014 Jul; 34(1):160-6. PubMed ID: 24827165
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-98 induces an Alzheimer's disease-like disturbance by targeting insulin-like growth factor 1.
Hu YK; Wang X; Li L; Du YH; Ye HT; Li CY
Neurosci Bull; 2013 Dec; 29(6):745-51. PubMed ID: 23740209
[TBL] [Abstract][Full Text] [Related]
15. Osthole decreases beta amyloid levels through up-regulation of miR-107 in Alzheimer's disease.
Jiao Y; Kong L; Yao Y; Li S; Tao Z; Yan Y; Yang J
Neuropharmacology; 2016 Sep; 108():332-44. PubMed ID: 27143098
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Effects of Transplantation of As-MiR-937-Expressing Mesenchymal Stem Cells in Murine Model of Alzheimer's Disease.
Liu Z; Wang C; Wang X; Xu S
Cell Physiol Biochem; 2015; 37(1):321-30. PubMed ID: 26316079
[TBL] [Abstract][Full Text] [Related]
17. Cerebrovascular miRNAs correlate with the clearance of Aβ through perivascular route in younger 3xTg-AD mice.
Fu L; Jiang G; Weng H; Dick GM; Chang Y; Kassab GS
Brain Pathol; 2020 Jan; 30(1):92-105. PubMed ID: 31206909
[TBL] [Abstract][Full Text] [Related]
18. Intrahippocampal miR-342-3p inhibition reduces β-amyloid plaques and ameliorates learning and memory in Alzheimer's disease.
Fu Y; Hu X; Zheng C; Sun G; Xu J; Luo S; Cao P
Metab Brain Dis; 2019 Oct; 34(5):1355-1363. PubMed ID: 31134481
[TBL] [Abstract][Full Text] [Related]
19. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
[TBL] [Abstract][Full Text] [Related]
20. Deacetylation of TFEB promotes fibrillar Aβ degradation by upregulating lysosomal biogenesis in microglia.
Bao J; Zheng L; Zhang Q; Li X; Zhang X; Li Z; Bai X; Zhang Z; Huo W; Zhao X; Shang S; Wang Q; Zhang C; Ji J
Protein Cell; 2016 Jun; 7(6):417-33. PubMed ID: 27209302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
